Abstract:Following the publication of the above article, an interested reader drew to the authors' attention that, in Fig. 5A on p. 1305, the same xenograft tumor image had been selected for a pair of the GFP/U2‐OS experiments, where the images from discretely performed experiments were intended to have been shown. Furthermore, upon performing an independent analysis of the data in the Editorial Office, it was noted that the data selected for the 'SaO2/GFP/24 h' and 'SaO2/HMGN2/48 h' experiments in Fig. 4A, also on p. 1305, were strikingly similar, such that the same data had apparently been chosen to show the results of differently performed experiments. After having inspected the figures, the authors realized that one of the n=3 experimental results had inadvertently been omitted from Fig. 5A, and the data shown to represent the 'SaO2/GFP/24 h' experiment had been chosen incorrectly. The revised and corrected versions of Figs. 4 and 5 are shown on the next page (also note that erroneously written labels have been corrected in Fig. 5C: "Tumor volume" has been replaced by "Tumor weight"). Note that the errors made in terms of the assembly of the data in these figures did not affect the overall conclusions reported in the paper. The authors are grateful to the Editor of Oncology Reports for granting them this opportunity to publish a Corrigendum, and apologize to boh the Editor and the readership for any inconvenience caused. [Oncology Reports 33: 1300‐1306, 2015; DOI: 10.3892/or.2014.3689]

Correction: Corrigendum: Mammalian Mon2/Ysl2 Regulates Endosome-to-golgi Trafficking but Possesses No Guanine Nucleotide Exchange Activity Toward Arl1 GTPase

Erratum: Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers

Correction: Corrigendum: Quantitative real-time imaging of glutathione

Correction: Corrigendum: Autophagy-associated alpha-arrestin signaling is required for conidiogenous cell development in Magnaporthe oryzae

Correction: Corrigendum: Lysine Acetylation and Succinylation in HeLa Cells and Their Essential Roles in Response to UV-induced Stress

Corrigendum for “lncrna EPB41L4A-AS1 Regulates Glycolysis and Glutaminolysis by Mediating Nucleolar Translocation of HDAC2” [ebiomedicine 41 (2019) 200–213]

Correction: Corrigendum: CMT2D Neuropathy is Linked to the Neomorphic Binding Activity of Glycyl-Trna Synthetase

Erratum: Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma

Corrigendum to "Zhang Y, Han X, Hu N, Huff AF, Gao F, Ren J. Akt2 knockout alleviates prolonged caloric restriction-induced change in cardiac contractile function through regulation of autophagy. [J Mol Cell Cardiol. 2014 Jun; 71:81-91. PMID: 24368095].

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Correction: Corrigendum: Inhibitory Receptors Bind ANGPTLs and Support Blood Stem Cells and Leukaemia Development

Correction: Corrigendum: The tRNA methyltransferase NSun2 stabilizes p16INK4 mRNA by methylating the 3′-untranslated region of p16

[Corrigendum] A Regulation Loop Between Nrf1α and MRTF‑A Controls Migration and Invasion in MDA‑MB‑231 Breast Cancer Cells.

Corrigendum: 3′ UTR Lengthening As a Novel Mechanism in Regulating Cellular Senescence

[Corrigendum] Nucleosome‐binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2‐OS osteosarcoma cell lines

Correction: Corrigendum: Structural basis for selective binding of m 6 A RNA by the YTHDC1 YTH domain

Correction to: Dual Functional Monocytes Modulate Bactericidal and Anti-Inflammation Process for Severe Osteomyelitis Treatment (Small, (2020), 16, 4, (1905185), 10.1002/smll.201905185)

Erratum: Corrigendum: Structural Basis for Selective Binding of M6a RNA by the YTHDC1 YTH Domain

Correction for Lin Et Al., “Epstein-Barr Virus-Encoded Latent Membrane Protein 2A Promotes the Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma Via Metastatic Tumor Antigen 1 and Mechanistic Target of Rapamycin Signaling Induction”

Corrigendum to “central Angiotensin II‐induced Alzheimer‐like Tau Phosphorylation in Normal Rat Brains” [FEBS Lett. 586 (2012) 3737–3745]

Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (Nature Nanotechnology, (2019), 14, 4, (388-397), 10.1038/s41565-019-0381-6)